BUSINESS COMBINATIONS AND ASSET PURCHASES - Schedule of Pro Forma Information (Details) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Ermont Acquisition | ||
| Business Acquisition [Line Items] | ||
| Revenue | $ 148,948 | $ 139,857 |
| Net (loss) income | $ (17,210) | 6,292 |
| Kind Therapeutics USA Inc. | ||
| Business Acquisition [Line Items] | ||
| Revenue | 136,078 | |
| Net (loss) income | $ 15,823 | |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|